Advanced search

Online first
Review paper
Published online: 2024-01-19

open access

View PDF Download PDF file
Supp./Additional Files
Page views 345
Article views/downloads 283
Get Citation

Connect on Social Media

Connect on Social Media

The use of cannabinoids and alternative therapies in chronic pain management: a narrative review

Grzegorz Łukasik1, Mateusz Guziak2, Zuzanna Bastrzyk1, Olga Szot3, Bartosz Kamil Sobocki4
DOI: 10.5603/pmp.98210

Abstract

Palliative care patients experience pain daily which significantly lowers their quality of life. Chronic pain is one of the main reasons why people contact health professionals, and its prevalence is about 20% in Europe and the United States. Comprehensive and sufficient pain management is often limited to medical facilities whereas patients suffering from chronic pain staying in their households often receive incomplete analgesia. Pharmacological recommendations were described with specific indications and contraindications for therapeutic regimens in relation to cancer patients under palliative care. The addition of alternative pain management techniques to the pharmacological treatment can contribute to better pain control and even lower doses of opioids administered. On the other hand, state-of-the-art studies evaluating their efficiency and mechanism of action are missing. This study summarizes a variety of alternative pain management methods and mechanisms behind their analgesic and co-analgesic effects that contribute to maximizing the pharmacological effect of analgesic drugs. This study aimed to gather alternative pain control options and assess their efficiency, status, and potential in palliative care settings. Moreover, this review tries to evaluate whether they are scientifically evidence-based or not.

Keywords: adjuvantsanalgesicspainsupportive carepalliative caresymptom management

Article available in PDF format

View PDF Download PDF file

References

  1. Henschke N, Kamper SJ, Maher CG. The epidemiology and economic consequences of pain. Mayo Clin Proc. 2015; 90(1): 139–147.
    CrossRefPubMed
  2. Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021; 397(10289): 2082–2097.
    CrossRefPubMed
  3. Steglitz J, Buscemi J, Ferguson MJ. The future of pain research, education, and treatment: a summary of the IOM report “Relieving pain in America: a blueprint for transforming prevention, care, education, and research”. Transl Behav Med. 2012; 2(1): 6–8.
    CrossRefPubMed
  4. Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012; 13(8): 715–724.
    CrossRefPubMed
  5. Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006; 10(4): 287–333.
    CrossRefPubMed
  6. Michaelides A, Zis P. Depression, anxiety and acute pain: links and management challenges. Postgrad Med. 2019; 131(7): 438–444.
    CrossRefPubMed
  7. Wilkie DJ, Ezenwa MO. Pain and symptom management in palliative care and at end of life. Nurs Outlook. 2012; 60(6): 357–364.
    CrossRefPubMed
  8. Henson LA, Maddocks M, Evans C, et al. Palliative care and the management of common distressing symptoms in advanced cancer: pain, breathlessness, nausea and vomiting, and fatigue. J Clin Oncol. 2020; 38(9): 905–914.
    CrossRefPubMed
  9. Alexander K, Goldberg J, Korc-Grodzicki B. Palliative care and symptom management in older patients with cancer. Clin Geriatr Med. 2016; 32(1): 45–62.
    CrossRefPubMed
  10. Williams N, Hermans K, Cohen J, et al. Prognosis does not change the landscape: palliative home care clients experience high rates of pain and nausea, regardless of prognosis. BMC Palliat Care. 2021; 20(1): 165.
    CrossRefPubMed
  11. Yoon SL, Scarton L, Duckworth L, et al. Pain, symptom distress, and pain barriers by age among patients with cancer receiving hospice care: Comparison of baseline data. J Geriatr Oncol. 2021; 12(7): 1068–1075.
    CrossRefPubMed
  12. Corli O, Pellegrini G, Bosetti C, et al. Impact of palliative care in evaluating and relieving symptoms in patients with advanced cancer. Results from the DEMETRA study. Int J Environ Res Public Health. 2020; 17(22).
    CrossRefPubMed
  13. Kong H, Liu Y, Wu K, et al. Pain and self-management status among chinese patients with cancer during the COVID-19 pandemic. Pain Manag Nurs. 2022; 23(1): 26–30.
    CrossRefPubMed
  14. Dy SM, Isenberg SR, Al Hamayel NA. Palliative care for cancer survivors. Med Clin North Am. 2017; 101(6): 1181–1196.
    CrossRefPubMed
  15. MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018; 49: 12–19.
    CrossRefPubMed
  16. Anand U, Pacchetti B, Anand P, et al. Cannabis-based medicines and pain: a review of potential synergistic and entourage effects. Pain Manag. 2021; 11(4): 395–403.
    CrossRefPubMed
  17. Verhamme KMC, Bohnen AM. Are we facing an opioid crisis in Europe? Lancet Public Health. 2019; 4(10): e483–e484.
    CrossRefPubMed
  18. van den Hoogen NJ, Harding EK, Davidson CED, et al. Cannabinoids in chronic pain: therapeutic potential through microglia modulation. Front Neural Circuits. 2021; 15: 816747.
    CrossRefPubMed
  19. Brown MRD, Farquhar-Smith WP. Cannabinoids and cancer pain: a new hope or a false dawn? Eur J Intern Med. 2018; 49: 30–36.
    CrossRefPubMed
  20. Blanton HL, Brelsfoard J, DeTurk N, et al. Cannabinoids: current and future options to treat chronic and chemotherapy-induced neuropathic pain. Drugs. 2019; 79(9): 969–995.
    CrossRefPubMed
  21. Chung M, Kim HK, Abdi S. Update on cannabis and cannabinoids for cancer pain. Curr Opin Anaesthesiol. 2020; 33(6): 825–831.
    CrossRefPubMed
  22. Wang Li, Hong PJ, May C, et al. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ. 2021; 374(n1034): 2448–2460.
    CrossRefPubMed
  23. Sihota A, Smith BK, Ahmed SA, et al. Consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain control. Int J Clin Pract. 2021; 75(8): e13871.
    CrossRefPubMed
  24. Capano A, Weaver R, Burkman E. Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study. Postgrad Med. 2020; 132(1): 56–61.
    CrossRefPubMed
  25. Johnson JR, Burnell-Nugent M, Lossignol D, et al. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010; 39(2): 167–179.
    CrossRefPubMed
  26. De Aquino JP, Meyerovich J, Xie CZ, et al. Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study. Addict Biol. 2023; 28(9): e13317.
    CrossRefPubMed
  27. De Vita MJ, Moskal D, Maisto SA, et al. Association of cannabinoid administration with experimental pain in healthy adults: a systematic review and meta-analysis. JAMA Psychiatry. 2018; 75(11): 1118–1127.
    CrossRefPubMed
  28. Lake S, Socías ME, Milloy MJ. Evidence shows that cannabis has fewer relative harms than opioids. CMAJ. 2020; 192(7): E166–E167.
    CrossRefPubMed
  29. Campbell CM, Mun CJ, Hamilton KR, et al. Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain. Neuropsychopharmacology. 2023; 48(11): 1630–1638.
    CrossRefPubMed
  30. Nielsen S, Picco L, Murnion B, et al. Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies. Neuropsychopharmacology. 2022; 47(7): 1315–1330.
    CrossRefPubMed
  31. Noori A, Miroshnychenko A, Shergill Y, et al. Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies. BMJ Open. 2021; 11(7): e047717.
    CrossRefPubMed
  32. McParland AL, Bhatia A, Matelski J, et al. Evaluating the impact of cannabinoids on sleep health and pain in patients with chronic neuropathic pain: a systematic review and meta-analysis of randomized controlled trials. Reg Anesth Pain Med. 2023; 48(4): 180–190.
    CrossRefPubMed
  33. Zubcevic K, Petersen M, Bach FW, et al. Oral capsules of tetra-hydro-cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatment. Eur J Pain. 2023; 27(4): 492–506.
    CrossRefPubMed
  34. Barakji J, Korang SK, Feinberg J, et al. Cannabinoids versus placebo for pain: a systematic review with meta-analysis and trial sequential analysis. PLoS One. 2023; 18(1): e0267420.
    CrossRefPubMed
  35. Zeraatkar D, Cooper MA, Agarwal A, et al. Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies. BMJ Open. 2022; 12(8): e054282.
    CrossRefPubMed
  36. Bilbao A, Spanagel R. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. BMC Med. 2022; 20(1): 259.
    CrossRefPubMed
  37. van Orten-Luiten ACB, de Roos NM, Majait S, et al. Effects of cannabidiol chewing gum on perceived pain and well-being of irritable bowel syndrome patients: a placebo-controlled crossover exploratory intervention study with symptom-driven dosing. Cannabis Cannabinoid Res. 2022; 7(4): 436–444.
    CrossRefPubMed
  38. Doeve BH, van de Meeberg MM, van Schaik FDM, et al. A systematic review with meta-analysis of the efficacy of cannabis and cannabinoids for inflammatory bowel disease: what can we learn from randomized and nonrandomized studies? J Clin Gastroenterol. 2021; 55(9): 798–809.
    CrossRefPubMed
  39. Chang L, Cash BD, Lembo A, et al. Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE). Neurogastroenterol Motil. 2023; 35(5): e14539.
    CrossRefPubMed
  40. Abrams DI, Couey P, Dixit N, et al. Effect of inhaled cannabis for pain in adults with sickle cell disease: a randomized clinical trial. JAMA Netw Open. 2020; 3(7): e2010874.
    CrossRefPubMed
  41. Vecchio D, Varrasi C, Virgilio E, et al. Cannabinoids in multiple sclerosis: a neurophysiological analysis. Acta Neurol Scand. 2020; 142(4): 333–338.
    CrossRefPubMed
  42. Russo M, Naro A, Leo A, et al. Evaluating sativex® in neuropathic pain management: a clinical and neurophysiological assessment in multiple sclerosis. Pain Med. 2016; 17(6): 1145–1154.
    CrossRefPubMed
  43. van de Donk T, Niesters M, Kowal MA, et al. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain. 2019; 160(4): 860–869.
    CrossRefPubMed
  44. de Vries M, van Rijckevorsel DCM, Vissers KCP, et al. Tetrahydrocannabinol does not reduce pain in patients with chronic abdominal pain in a phase 2 placebo-controlled study. Clin Gastroenterol Hepatol. 2017; 15(7): 1079–1086.e4.
    CrossRefPubMed
  45. Hoggart B, Ratcliffe S, Ehler E, et al. A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain. J Neurol. 2015; 262(1): 27–40.
    CrossRefPubMed
  46. Serpell M, Ratcliffe S, Hovorka J, et al. A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. Eur J Pain. 2014; 18(7): 999–1012.
    CrossRefPubMed
  47. Wallace MS, Marcotte TD, Atkinson JH, et al. A secondary analysis from a randomized trial on the effect of plasma tetrahydrocannabinol levels on pain reduction in painful diabetic peripheral neuropathy. J Pain. 2020; 21(11-12): 1175–1186.
    CrossRefPubMed
  48. Almog S, Aharon-Peretz J, Vulfsons S, et al. The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial. Eur J Pain. 2020; 24(8): 1505–1516.
    CrossRefPubMed
  49. Bialas P, Fitzcharles MA, Klose P, et al. Long-term observational studies with cannabis-based medicines for chronic non-cancer pain: a systematic review and meta-analysis of effectiveness and safety. Eur J Pain. 2022; 26(6): 1221–1233.
    CrossRefPubMed
  50. Gedin F, Blomé S, Pontén M, et al. Placebo response and media attention in randomized clinical trials assessing cannabis-based therapies for pain: a systematic review and meta-analysis. JAMA Netw Open. 2022; 5(11): e2243848.
    CrossRefPubMed
  51. Dieterle M, Zurbriggen L, Mauermann E, et al. Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II). Pain. 2022; 163(10): 1919–1928.
    CrossRefPubMed
  52. Garza-Villarreal EA, Pando V, Vuust P, et al. Music-induced analgesia in chronic pain conditions: a systematic review and meta-analysis. Pain Physician. 2017; 20(7): 597–610.
    PubMed
  53. Goksan S, Baxter L, Moultrie F, et al. The influence of the descending pain modulatory system on infant pain-related brain activity. Elife. 2018; 11(7).
    CrossRefPubMed
  54. Lin CL, Hwang SL, Jiang P, et al. Effect of music therapy on pain after orthopedic surgery-a systematic review and meta-analysis. Pain Pract. 2020; 20(4): 422–436.
    CrossRefPubMed
  55. Huang E, Huang J. Music therapy: a noninvasive treatment to reduce anxiety and pain of colorectal cancer patients-a systemic literature review. Medicina (Kaunas). 2023; 59(3).
    CrossRefPubMed
  56. Tang H, Chen L, Wang Y, et al. The efficacy of music therapy to relieve pain, anxiety, and promote sleep quality, in patients with small cell lung cancer receiving platinum-based chemotherapy. Support Care Cancer. 2021; 29(12): 7299–7306.
    CrossRefPubMed
  57. Warth M, Keßler J, Hillecke TK, et al. Music therapy in palliative care. Dtsch Arztebl Int. 2015; 112(46): 788–794.
    CrossRefPubMed
  58. Lee JH, Lee JH. The effects of music on pain: a meta-analysis. J Music Ther. 2016; 53(4): 430–477.
    CrossRefPubMed
  59. Gutgsell KJo, Schluchter M, Margevicius S, et al. Music therapy reduces pain in palliative care patients: a randomized controlled trial. J Pain Symptom Manage. 2013; 45(5): 822–831.
    CrossRefPubMed
  60. Li Y, Xing X, Shi X, et al. The effectiveness of music therapy for patients with cancer: A systematic review and meta-analysis. J Adv Nurs. 2020; 76(5): 1111–1123.
    CrossRefPubMed
  61. Koehler F, Kessler J, Stoffel M, et al. Psychoneuroendocrinological effects of music therapy versus mindfulness in palliative care: results from the 'Song of Life' randomized controlled trial. Support Care Cancer. 2022; 30(1): 625–634.
    CrossRefPubMed
  62. Knoerl R, Lavoie Smith EM, Weisberg J. Chronic pain and cognitive behavioral therapy: an integrative review. West J Nurs Res. 2016; 38(5): 596–628.
    CrossRefPubMed
  63. Melzack R. From the gate to the neuromatrix. Pain. 1999; 82(Suppl 6): S121–S126.
    CrossRefPubMed
  64. Seminowicz DA, Shpaner M, Keaser ML, et al. Cognitive-behavioral therapy increases prefrontal cortex gray matter in patients with chronic pain. J Pain. 2013; 14(12): 1573–1584.
    CrossRefPubMed
  65. Saxena AK, Bhardwaj N, Chilkoti GT, et al. Modulation of mRNA expression of IL-6 and mTORC1 and efficacy and feasibility of an integrated approach encompassing cognitive behavioral therapy along with pregabalin for management of neuropathic pain in postherpetic neuralgia: a pilot study. Pain Med. 2021; 22(10): 2276–2282.
    CrossRefPubMed
  66. Zhao YT, Deng J, Liu HM, et al. Adaptation of prelimbic cortex mediated by IL-6/STAT3/Acp5 pathway contributes to the comorbidity of neuropathic pain and depression in rats. J Neuroinflammation. 2022; 19(1): 144.
    CrossRefPubMed
  67. Darnall BD, Roy A, Chen AL, et al. Comparison of a single-session pain management skills intervention with a single-session health education intervention and 8 sessions of cognitive behavioral therapy in adults with chronic low back pain: a randomized clinical trial. JAMA Netw Open. 2021; 4(8): e2113401.
    CrossRefPubMed
  68. Rodin G, Malfitano C, Rydall A, et al. Emotion And Symptom-focused Engagement (EASE): a randomized phase II trial of an integrated psychological and palliative care intervention for patients with acute leukemia. Support Care Cancer. 2020; 28(1): 163–176.
    CrossRefPubMed
  69. García-Dasí M, Pérez-Alenda S, Carrasco JJ, et al. Effects of a non-pharmacological approach for chronic pain management in patients with haemophilia: efficacy of cognitive-behavioural therapy associated with physiotherapy. Haemophilia. 2021; 27(3): e357–e367.
    CrossRefPubMed
  70. Serrat M, Sanabria-Mazo JP, Almirall M, et al. Effectiveness of a multicomponent treatment based on pain neuroscience education, therapeutic exercise, cognitive behavioral therapy, and mindfulness in patients with fibromyalgia (FIBROWALK study): a randomized controlled trial. Phys Ther. 2021; 101(12).
    CrossRefPubMed
  71. McCrae CS, Williams J, Roditi D, et al. Cognitive behavioral treatments for insomnia and pain in adults with comorbid chronic insomnia and fibromyalgia: clinical outcomes from the SPIN randomized controlled trial. Sleep. 2019; 42(3).
    CrossRefPubMed
  72. Borisovskaya A, Chmelik E, Karnik A. Exercise and chronic pain. Adv Exp Med Biol. 2020; 1228: 233–253.
    CrossRefPubMed
  73. Ambrose KR, Golightly YM. Physical exercise as non-pharmacological treatment of chronic pain: Why and when. Best Pract Res Clin Rheumatol. 2015; 29(1): 120–130.
    CrossRefPubMed
  74. Geneen LJ, Moore RA, Clarke C, et al. Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017; 1(1): CD011279.
    CrossRefPubMed
  75. Sluka KA, Frey-Law L, Hoeger Bement M. Exercise-induced pain and analgesia? Underlying mechanisms and clinical translation. Pain. 2018; 159 Suppl 1(Suppl 1): S91–S97.
    CrossRefPubMed
  76. Calapai M, Puzzo L, Bova G, et al. Effects of physical exercise and motor activity on oxidative stress and inflammation in post-mastectomy pain syndrome. Antioxidants (Basel). 2023; 12(3).
    CrossRefPubMed
  77. Naugle KM, Fillingim RB, Riley JL. A meta-analytic review of the hypoalgesic effects of exercise. J Pain. 2012; 13(12): 1139–1150.
    CrossRefPubMed
  78. Daenen L, Varkey E, Kellmann M, et al. Exercise, not to exercise, or how to exercise in patients with chronic pain? Applying science to practice. Clin J Pain. 2015; 31(2): 108–114.
    CrossRefPubMed
  79. Nijs Jo, Kosek E, Van Oosterwijck J, et al. Dysfunctional endogenous analgesia duringexercise in patients with chronic pain: toexercise or not to exercise? Pain Physician. 2012; 15: ES205–ES213.
  80. Aitken D, Buchbinder R, Jones G, et al. Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults. Aust Fam Physician. 2015; 44(1-2): 39–42.
    PubMed
  81. Nijs Jo, Lluch Girbés E, Lundberg M, et al. Exercise therapy for chronic musculoskeletal pain: Innovation by altering pain memories. Man Ther. 2015; 20(1): 216–220.
    CrossRefPubMed
  82. Slade SC, Patel S, Underwood M, et al. What are patient beliefs and perceptions about exercise for nonspecific chronic low back pain? A systematic review of qualitative studies. Clin J Pain. 2014; 30(11): 995–1005.
    CrossRefPubMed
  83. Bernal-Utrera C, Gonzalez-Gerez JJ, Anarte-Lazo E, et al. Manual therapy versus therapeutic exercise in non-specific chronic neck pain: a randomized controlled trial. Trials. 2020; 21(1): 682.
    CrossRefPubMed
  84. Fernández-Rodríguez R, Álvarez-Bueno C, Cavero-Redondo I, et al. Best exercise options for reducing pain and disability in adults with chronic low back pain: pilates, strength, core-based, and mind-body. A network meta-analysis. J Orthop Sports Phys Ther. 2022; 52(8): 505–521.
    CrossRefPubMed
  85. Yee J, Davis GM, Hackett D, et al. Physical activity for symptom management in women with metastatic breast cancer: a randomized feasibility trial on physical activity and breast metastases. J Pain Symptom Manage. 2019; 58(6): 929–939.
    CrossRefPubMed
  86. Klein I, Kalichman L, Chen N, et al. Effect of physical activity levels on oncological breast surgery recovery: a prospective cohort study. Sci Rep. 2021; 11(1): 10432.
    CrossRefPubMed
  87. Zhu M, Huang H. The underlying mechanisms of sleep deprivation exacerbating neuropathic pain. Nat Sci Sleep. 2023; 15: 579–591.
    CrossRefPubMed
  88. Ding W, Yang L, Shi E, et al. The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption. Nat Commun. 2023; 14(1): 6696.
    CrossRefPubMed
  89. Izquierdo-Alventosa R, Inglés M, Cortés-Amador S, et al. Low-Intensity physical exercise improves pain catastrophizing and other psychological and physical aspects in women with fibromyalgia: a randomized controlled trial. Int J Environ Res Public Health. 2020; 17(10).
    CrossRefPubMed
  90. López-Sendín N, Alburquerque-Sendín F, Cleland JA, et al. Effects of physical therapy on pain and mood in patients with terminal cancer: a pilot randomized clinical trial. J Altern Complement Med. 2012; 18(5): 480–486.
    CrossRefPubMed
  91. Barker K, Eickmeyer S. Therapeutic Exercise. Med Clin North Am. 2020; 104(2): 189–198.
    CrossRefPubMed
  92. Wagner B, Steiner M, Huber DF, et al. The effect of biofeedback interventions on pain, overall symptoms, quality of life and physiological parameters in patients with pelvic pain: a systematic review. Wien Klin Wochenschr. 2022; 134(Suppl 1): 11–48.
    CrossRefPubMed
  93. Tolin DF, Davies CD, Moskow DM, et al. Biofeedback and neurofeedback for anxiety disorders: a quantitative and qualitative systematic review. Adv Exp Med Biol. 2020; 1191: 265–289.
    CrossRefPubMed
  94. Prinsloo S, Novy D, Driver L, et al. Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study. Cancer. 2017; 123(11): 1989–1997.
    CrossRefPubMed
  95. Stern MJ, Guiles RAF, Gevirtz R. HRV biofeedback for pediatric irritable bowel syndrome and functional abdominal pain: a clinical replication series. Appl Psychophysiol Biofeedback. 2014; 39(3-4): 287–291.
    CrossRefPubMed
  96. Yetwin AK, Mahrer NE, Bell TS, et al. Heart rate variability biofeedback therapy for children and adolescents with chronic pain: a pilot study. J Pediatr Nurs. 2022; 66: 151–159.
    CrossRefPubMed
  97. Liao GS, Apaya MK, Shyur LF. Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy. Evid Based Complement Alternat Med. 2013: 437948.
    CrossRefPubMed
  98. Vickers AJ, Vertosick EA, Lewith G, et al. Acupuncture for chronic pain: update of an individual patient data meta-analysis. J Pain. 2018; 19(5): 455–474.
    CrossRefPubMed
  99. Liang Qi, Zhang Ke, Wang S, et al. Acupuncture for cancer pain – an adjuvant therapy for cancer pain relief. Am J Chin Med. 2020; 48(8): 1769–1786.
    CrossRefPubMed
  100. Zhang WT, Jin Z, Cui GH, et al. Relations between brain network activation and analgesic effect induced by low vs. high frequency electrical acupoint stimulation in different subjects: a functional magnetic resonance imaging study. Brain Res. 2003; 982(2): 168–178.
    CrossRefPubMed
  101. Pariente J, White P, Frackowiak RSJ, et al. Expectancy and belief modulate the neuronal substrates of pain treated by acupuncture. Neuroimage. 2005; 25(4): 1161–1167.
    CrossRefPubMed
  102. Oh JE, Kim SN. Anti-Inflammatory effects of acupuncture at ST36 point: a literature review in animal studies. Front Immunol. 2021; 12: 813748.
    CrossRefPubMed
  103. Zeng D, Yan X, Deng H, et al. Placebo response varies between different types of sham acupuncture: A randomized double-blind trial in neck pain patients. Eur J Pain. 2022; 26(5): 1006–1020.
    CrossRefPubMed
  104. Kotani N, Hashimoto H, Sato Y, et al. Preoperative intradermal acupuncture reduces postoperative pain, nausea and vomiting, analgesic requirement, and sympathoadrenal responses. Anesthesiology. 2001; 95(2): 349–356.
    CrossRefPubMed
  105. Zhou X, Cao SG, Tan XJ, et al. Effects of transcutaneous electrical acupoint stimulation (TEAS) on postoperative recovery in patients with gastric cancer: a randomized controlled trial. Cancer Manag Res. 2021; 13: 1449–1458.
    CrossRefPubMed
  106. Robinson CL, Berger A, Sottosanti E, et al. Acupuncture as part of multimodal analgesia for chronic pain. Orthop Rev (Pavia). 2022; 14(3): 38321.
    CrossRefPubMed
  107. Wong YK, Wu JM, Zhou G, et al. Antidepressant monotherapy and combination therapy with acupuncture in depressed patients: a resting-state functional near-infrared spectroscopy (fnirs) study. Neurotherapeutics. 2021; 18(4): 2651–2663.
    CrossRefPubMed
  108. Pei L, Geng H, Guo J, et al. Effect of acupuncture in patients with irritable bowel syndrome: a randomized controlled trial. Mayo Clin Proc. 2020; 95(8): 1671–1683.
    CrossRefPubMed
  109. Berger AA, Liu Y, Nguyen J, et al. Efficacy of acupuncture in the treatment of fibromyalgia. Orthop Rev (Pavia). 2021; 13(2): 25085.
    CrossRefPubMed
  110. Ben-Arye E, Hausner D, Samuels N, et al. Impact of acupuncture and integrative therapies on chemotherapy-induced peripheral neuropathy: A multicentered, randomized controlled trial. Cancer. 2022; 128(20): 3641–3652.
    CrossRefPubMed
  111. Ben-Arye E, Gamus D, Samuels N, et al. Acupuncture and integrative oncology for taxane-induced peripheral neuropathy: a randomized multicentered study. Int J Gynecol Cancer. 2023; 33(5): 792–801.
    CrossRefPubMed
  112. Jin M, Xie L, Mao Ni, et al. The characteristics of registered acupuncture clinical trials enrolling cancer patients. Support Care Cancer. 2022; 30(12): 10461–10470.
    CrossRefPubMed
  113. Halámková J, Dymáčková R, Adámková Krákorová D. Acupuncture from the perspective of evidence-based medicine - options of clinical use based on National Comprehensive Cancer Network (NCCN) guidelines. Klin Onkol. 2022; 35(2): 94–99.
    CrossRefPubMed
  114. Brøndum L, Markfoged B, Finderup J. Acupuncture as a tool to reduce nausea in terminally ill patients. Scand J Caring Sci. 2022; 36(4): 1046–1053.
    CrossRefPubMed
  115. Meng Z, Garcia MK, Hu C, et al. Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma. Cancer. 2012; 118(13): 3337–3344.
    CrossRefPubMed
  116. Mao J, Ismaila N, Bao T, et al. Integrative medicine for pain management in oncology: society for integrative oncology–asco guideline. J Clin Oncol. 2022; 40(34): 3998–4024.
    CrossRefPubMed
  117. Harris RE, Zubieta JK, Scott DJ, et al. Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs). Neuroimage. 2009; 47(3): 1077–1085.
    CrossRefPubMed
  118. Prinsloo S, Rosenthal DI, Garcia MK, et al. Cross-Cultural brain activity differences between true and sham acupuncture for xerostomia during head and neck cancer radiotherapy. Integr Cancer Ther. 2022; 21.
    CrossRefPubMed
  119. Lau CHY, Wu X, Chung VCH, et al. Acupuncture and related therapies for symptom management in palliative cancer care: systematic review and meta-analysis. Medicine (Baltimore). 2016; 95(9): e2901.
    CrossRefPubMed
  120. Romeo MJ, Parton B, Russo RA, et al. Acupuncture to treat the symptoms of patients in a palliative care setting. Explore (NY). 2015; 11(5): 357–362.
    CrossRefPubMed
  121. Fink J, Burns J, Perez Moreno AC, et al. A quality brief of an oncological multisite massage and acupuncture therapy program to improve cancer-related outcomes. J Altern Complement Med. 2020; 26(9): 820–824.
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Copyright © 2023 Via Medica Regulations Cookie policy Privacy policy Legal Notice